Gamma Investing LLC Prothena Corp Public LTD CO Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Gamma Investing LLC holds 127 shares of PRTA stock, worth $1,657. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127
Previous 67
89.55%
Holding current value
$1,657
Previous $1.12 Million
56.91%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$151 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$54.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$50.3 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$49.9 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$22.7 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $612M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...